Skip to main content

Want a detailed portfolio tracker?

Precision Biosciences (DTIL) P/E (2019 - 2026)

Precision Biosciences (DTIL) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Precision Biosciences (DTIL) P/E is -2.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Precision Biosciences (DTIL)

YearP/EChange
2026-2.06+144.26%
2025-0.84-132.78%
20242.57-560.45%
2023-0.56-38.09%
2022-0.90-93.72%
2021-14.35+259.99%
2020-3.99-65.44%
2019-11.54N/A

Comparison Precision Biosciences (DTIL) P/E with competitors

Precision Biosciences (DTIL) P/E is -2.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.63%
FGENFibroGen Inc0.24-111.66%
CHRSCoherus Biosciences Inc0.85-141.22%
FBIOFortress Biotech Inc0.95-146.10%
ORMPOramed Pharmaceuticals Inc1.50-173.02%
AGENAgenus Inc3.01-246.20%
INVAInnoviva Inc3.15-253.22%
VXRTVaxart Inc3.55-272.44%
CRMDCorMedix Inc3.63-276.26%
CVACCureVac N.V.4.45-315.96%
GLPGGalapagos NV4.86-336.04%
SRPTSarepta Therapeutics Inc4.88-337.16%
ABEOAbeona Therapeutics Inc5.39-361.71%
ABUSArbutus Biopharma Corp5.60-371.82%
ZVRAZevra Therapeutics Inc5.89-385.99%
SPROSpero Therapeutics Inc6.23-402.57%
CGENCompugen Ltd6.31-406.72%
RIGLRigel Pharmaceuticals6.87-433.83%
SLXNSilexion Therapeutics Corp7.30-454.43%
OMEROmeros Corporation9.26-549.77%
AUPHAurinia Pharmaceuticals Inc9.58-565.62%
PLXProtalix BioTherapeutics Inc10.89-629.06%
ACADAcadia Pharmaceuticals Inc11.73-669.75%
TBPHTheravance Biopharma Inc12.26-695.67%
ADMAAdma Biologics Inc12.42-703.25%
HRMYHarmony Biosciences Holdings Inc13.82-771.36%
SABSSAB Biotherapeutics Inc14.14-786.71%
NAGENiagen Bioscience Inc14.82-819.84%
INCYIncyte Corp15.82-868.63%
REGNRegeneron Pharmaceuticals Inc15.86-870.29%
PBYIPuma Biotechnology Inc17.32-941.17%
CPRXCatalyst Pharmaceuticals Inc17.44-947.17%
EXELExelixis Inc17.54-951.97%
TGTXTG Therapeutics Inc18.97-1021.34%
MDXGMimedx Group Inc20.55-1098.41%
XOMAXOMA Royalty Corp22.87-1211.24%
ARGXArgen X SE24.30-1280.39%
CTMXCytomX Therapeutics Inc24.82-1305.80%
XOMAOXOMA Royalty Corp25.34-1331.24%
HALOHalozyme Therapeutics Inc25.62-1344.79%
XOMAPXOMA Royalty Corp25.67-1347.04%
VRTXVertex Pharmaceuticals Inc27.99-1459.97%
RPRXRoyalty Pharma plc - Class A28.69-1493.63%
SLNOSoleno Therapeutics Inc29.02-1509.55%
ASNDAscendis Pharma A/S30.09-1561.54%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1941.75%
APLSApellis Pharmaceuticals Inc39.02-1995.63%
BMRNBiomarin Pharmaceutical Inc42.21-2150.63%
KRYSKrystal Biotech Inc45.34-2302.77%
ONCBeiGene Ltd69.54-3478.24%
PHARPharming Group N.V.75.03-3744.71%
TECHBio-Techne Corp101.96-5053.09%
VCELVericel Corp109.92-5439.93%
ALNYAlnylam Pharmaceuticals Inc117.96-5830.69%
GMABGenmab140.29-6915.27%
TLXTelix Pharmaceuticals Ltd162.15-7977.32%
CORTCorcept Therapeutics Inc212.86-10440.53%